Eagle Bay Advisors LLC Johnson & Johnson Transaction History

Eagle Bay Advisors LLC

$170 Million
Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 5,042 shares of JNJ stock, worth $728,417. This represents 0.48% of its overall portfolio holdings.

Number of Shares

5,042

Previous 4,928 2.31%

Holding current value

$728,417

Previous $720,000 13.47%

% of portfolio

0.48%

Previous 0.44%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$145.48 - $167.38 $16,584 - $19,081	114 Added 2.31%	5,042 $817,000
Q2 2024 Jul 26, 2024	SELL	$144.38 - $157.78 $74,500 - $81,414	-516 Reduced 9.48%	4,928 $720,000
Q1 2024 May 08, 2024	SELL	$155.22 - $162.74 $18,936 - $19,854	-122 Reduced 2.19%	5,444 $861,000
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $65,083 - $71,019	-447 Reduced 7.43%	5,566 $872,000
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $272,874 - $305,688	1,752 Added 41.12%	6,013 $936,000
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $9,878 - $10,631	-64 Reduced 1.48%	4,261 $705,000
Q1 2023 Apr 24, 2023	SELL	$151.05 - $180.26 $110,266 - $131,589	-730 Reduced 14.44%	4,325 $670,000
Q4 2022 Jan 26, 2023	SELL	$160.2 - $179.79 $24,030 - $26,968	-150 Reduced 2.88%	5,055 $0
Q3 2022 Nov 22, 2022	SELL	$161.33 - $179.52 $21,618 - $24,055	-134 Reduced 2.51%	5,205 $852,000
Q2 2022 Aug 19, 2022	BUY	$168.19 - $186.01 $77,703 - $85,936	462 Added 9.47%	5,339 $948 Million
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $33,367 - $37,893	211 Added 4.52%	4,877 $864,000
Q4 2021 Jan 21, 2022	SELL	$155.93 - $173.01 $232,023 - $257,438	-1,488 Reduced 24.18%	4,666 $799,000
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $243,542 - $270,640	1,508 Added 32.46%	6,154 $991,000
Q2 2021 Jul 30, 2021	BUY	$159.48 - $171.07 $740,944 - $794,791	4,646 New	4,646 $770,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $378B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Johnson & Johnson Transaction History